Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $125.8600 (1.72%) ($122.7000 - $126.1700) on Sat. Jul. 9, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.74% (three month average) | RSI | 75 | Latest Price | $125.8600(1.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.1% a day on average for past five trading days. | Weekly Trend | LGND advances 4.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting LGND price | LGND will decline at least -0.87% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.87% (StdDev 1.74%) | Hourly BBV | 0 () | Intraday Trend | 1.9% | | | |
|
5 Day Moving Average | $123.65(1.79%) | 10 Day Moving Average | $120.41(4.53%) | 20 Day Moving Average | $117.47(7.14%) | To recent high | -3.5% | To recent low | 12.6% | Market Cap | $N/A | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |